New Delhi: Vaccines are the only option in India so far to fight the deadly coronavirus, but it appears that an oral antiviral drug will soon be allowed to use as an emergency to treat moderate to mild COVID-19 cases. Dr Ram Vishwakarma, Chairman, Covid Strategy Group, CSIR, said that Mark's antiviral drug Molnupiravir may get approval for emergency use in the coming days, saying it may take some more time for another Pfizer tablet, Paxlovid, to arrive.
He claimed that these pills will make a big difference. Calling the drugs the final nail in the coffin of the virus from the side of science, he said that I think Molnupiravir will already be available for us. Five companies are sitting with the drugmaker and I think someday we will get the approval of Molnupiravir. He said that the data of Molnupiravir is lying here with the regulator before the permission of the UK regulator.
He said that already SEC is looking at it and I think it will now get approval faster and so it would be safe to say that within the next one month, the approval for the merc drug will be decided. Talking about the price of the medicine, he said that initially, the price can range from Rs. 2000 to Rs. 4000 and later it can range from Rs. 500 to Rs. 1000.